JPMorgan initiated coverage on Cholamandalam Investment with an underweight rating and a target price of Rs 600. The stock closed at Rs 786 on 29 August. The global investment bank expects earnings to disappoint over FY23/24. There is competition from banks that can drive margin compression, said the note. It believes that markets have ascribed a significant valuation premium to the stock.
Wakefit IPO: Check GMP, price band, review, subscription and other details
Wakefit Innovations, known for its mattresses, is launching its IPO with a positive grey market outlook. The company is raising over Rs 1,200 crore. Despite